Thermo Fisher Scientific Inc

$ 270.75 1.2 (0.45%)
Volume: 612,982 Avg Vol (1m): 1,652,846
Market Cap $: 108.23 Bil Enterprise Value $: 125.12 Bil
P/E (TTM): 37.32 P/B: 3.96
Earnings Power Value 56.76
Net Current Asset Value -44.76
Tangible Book -31.64
Projected FCF 150.51
Median P/S Value 167.98
Graham Number 0
Peter Lynch Value 87.15
DCF (FCF Based) 169.46
DCF (Earnings Based) 132.66
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.11
Equity-to-Asset 0.49
Debt-to-Equity 0.69
Debt-to-EBITDA 3.07
Interest Coverage 5.75
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.48
DISTRESS
GREY
SAFE
Beneish M-Score -2.52
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 7.67%
WACC 9.22%

Profitability & Growth : 8/10

Current vs industry vs history
Operating Margin % 15.74
Net Margin % 12.06
ROE % 11.09
ROA % 5.25
ROC (Joel Greenblatt) % 51.63
3-Year Total Revenue Growth Rate 12.80
3-Year Total EBITDA Growth Rate 15.30
3-Year EPS w/o NRI Growth Rate 13.70

» TMO's 30-Y Financials

Financials (Next Earnings Date: 2019-07-25)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:TMO

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Diagnostics & Research    NAICS : 541380    SIC : 3826
Compare NYSE:DHR XAMS:PHIA NYSE:A NYSE:IQV TSE:6869 XSWX:LONN NYSE:LH NAS:IDXX NYSE:DGX XTER:SRT3 SZSE:300676 XPAR:BIM XPAR:ERF NYSE:PKI NYSE:BIO NYSE:QGEN NAS:DXCM NAS:ICLR NAS:EXAS XTER:AFX
Traded in other countries TMOS34.Brazil TN8.Germany TFS.Switzerland 0R0H.UK
Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments: analytical technologies (about 22% of sales after the FEI acquisition); specialty diagnostic products (16%); life science solutions (26% including Affymetrix); and lab products and services (36% including Patheon and excluding cross-segment sales).

Ratios

Current vs industry vs history
PE Ratio (TTM) 37.32
Forward PE Ratio 22.12
N/A
PE Ratio without NRI 37.32
Price-to-Owner-Earnings 28.15
PB Ratio 3.96
PS Ratio 4.51
Price-to-Free-Cash-Flow 29.03
Price-to-Operating-Cash-Flow 24.19
EV-to-EBIT 31.84
EV-to-EBITDA 20.20
EV-to-Revenue 5.14
PEG Ratio 2.74
Shiller PE Ratio 60.39
Current Ratio 1.73
Quick Ratio 1.24
Days Inventory 79.56
Days Sales Outstanding 61.98
Days Payable 43.66

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.26
Dividend Payout Ratio 0.09
3-Year Dividend Growth Rate (Per Share) 4.30
Forward Dividend Yield % 0.28
N/A
Yield-on-Cost (5-Year) % 0.30
3-Year Share Buyback Rate -0.20

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.80
Price-to-DCF (Earnings Based) 2.04
Price-to-Median-PS-Value 1.61
Price-to-Peter-Lynch-Fair-Value 3.11
Earnings Yield (Joel Greenblatt) % 3.14
Forward Rate of Return (Yacktman) % 14.70

More Statistics

Revenue (TTM) (Mil) $ 24,358
EPS (TTM) $ 7.25
Beta 1.3
Volatility % 21.8
52-Week Range $ 202.83 - 282.98
Shares Outstanding (Mil) 399.97

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N